Article
Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome
4 Sept 2015
Abstract excerpt
// Katia Rea 1 , Patrizia Pinciroli 2 , Marialuisa Sensi 2 , Federica Alciato 3 , Brigitte Bisaro 4 , Ludmila Lozneanu 5 , Francesco Raspagliesi 6 , Floriana Centritto 2 , Sara Cabodi 4 , Paola Defilippi 4 , Gian Carlo Avanzi 3 , Silvana Canevari 2 , Antonella Tomassetti 1 1 Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
